Sort
21,281 grants matching “influenza”
Influenza Viral Pathogenesis
$1,234,735Jeffery Taubenberger · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
IP21-002 Enhanced Surveillance for New Vaccine Preventable Diseases
$1,234,285Natasha Bassam Halasa · Vanderbilt University Medical Center · U01 · FY2024 · IP
IP21-002, New Vaccine Surveillance Network
$1,234,285Marian G Michaels · University Of Pittsburgh At Pittsburgh · U01 · FY2024 · IP
IP21-002, Surveillance for Vaccine Preventable Disease in Children
$1,234,285Julie Anne Boom · Baylor College Of Medicine · U01 · FY2024 · IP
IP21-002, Enhanced Surveillance to Assess Vaccine Preventable Enteric and Respiratory Virus Illnesses
$1,234,285Janet A Englund · Seattle Children'S Hospital · U01 · FY2024 · IP
IP21-002, US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children
$1,234,285Rangaraj Selvarangan · Children'S Mercy Hosp (Kansas City, Mo) · U01 · FY2024 · IP
IP21-002, Enhanced Surveillance Network for Enteric and Respiratory Viruses in Children: Assessing Disease Burden, Natural History, and Vaccine Effectiveness
$1,234,285Geoffrey Alan Weinberg · University Of Rochester · U01 · FY2024 · IP
IP21-002 US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children
$1,234,285Mary A Staat · Cincinnati Childrens Hosp Med Ctr · U01 · FY2024 · IP
Epithelial stem/progenitor cells as repair agents in diffuse alveolar damage
$1,233,079Harold A Chapman · University Of California, San Francisco · U01 · FY2019 · HL
Vaccine and Treatment Evaluation Units (VTEU)
$1,232,898Hana M El Sahli · Baylor College Of Medicine · UM1 · FY2022 · AI
Clinical Interventional Studies of HIV Reservoirs
$1,232,245Frank Maldarelli · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Public Health Epidemiology of Influenza Virus Infection and Control in China
$1,231,928Hong Chen · Chinese Ctr-Disease Control/Prevention · U01 · FY2018 · IP
Detection, prevention and treatment of acute myeloid leukemia (AML) relapse.
$1,231,558Christopher Hourigan · National Heart, Lung, And Blood Institute · ZIA · FY2014 · HL
Mechanisms of Effective Humoral Immune Responses to HIV-1
$1,230,841Mark Connors · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Mechanisms Of Humoral Evasion
$1,227,402Peter D Kwong · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Enhanced Surveillance for New Vaccine Preventable Diseases
$1,226,950Janet A Englund · Seattle Children'S Hospital · U01 · FY2018 · IP
New Vaccine Surveillance Network
$1,226,950John V Williams · University Of Pittsburgh At Pittsburgh · U01 · FY2018 · IP
Enhanced Surveillance for New Vaccine Preventable Diseases
$1,226,950Natasha Bassam Halasa · Vanderbilt University Medical Center · U01 · FY2018 · IP
Enhanced Surveillance for Newly preventable Diseases (ARI and AGE Surveillance) Rochester, NY
$1,226,950Geoffrey Alan Weinberg · University Of Rochester · U01 · FY2018 · IP
Enhanced Surveillance for New Vaccine Preventable Diseases
$1,226,950Julie Anne Boom · Texas Children'S Hospital · U01 · FY2018 · IP
Kansas City - New Vaccine Surveillance Network (KC-NVSN)
$1,226,942Rangaraj Selvarangan · Children'S Mercy Hosp (Kansas City, Mo) · U01 · FY2018 · IP
Computational Models of Adaptive Immunity to Influenza
$1,225,986Sarah Cobey · University Of Chicago · U01 · FY2025 · AI
Therapeutic Monoclonal Antibodies to H5N1 Influenza
$1,225,983Richard John Webby · St. Jude Children'S Research Hospital · U01 · FY2007 · AI
Surveillance and Response to Avian and Pandemic Influenza in Vietam
$1,225,000Nguyen Van Binh · Vietnam Ministry Of Health · U51 · FY2008 · CI
Structural Biology Of Virus Assembly
$1,224,707Alasdair C. Steven · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2015 · AR